Learn, Analyse & Invest
only with
only with
+91
Download Orca
Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Phar
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Mid-cap - With a market cap of ₹558.75 Cr.
Financial Strength
Stable
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 55875.19 Cr.
Enterprise Value
₹ 54474 Cr.
Shares Outstanding
16.94 Cr.
Dividend Yield
1.64%
Face Value
₹ 10
Book Value
₹ 115.94
TTM EPS
54.25 Cr.
TTM-PE
60.8
Latest Equity
169.41
Latest Reserve
₹ 1795
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Ipca Laboratories | Loading... | Mid-cap | 57.39 | 4.96 | 21.57 | 8.7 |
| Ajanta Pharma | Loading... | Small-cap | 35.53 | 8.64 | 73.69 | 25.06 |
| Pfizer | Loading... | Small-cap | 23.86 | 4.34 | 167.78 | 19.65 |
| Glenmark Pharma | Loading... | Mid-cap | 44.14 | 1.39 | 10.53 | 4.07 |
| Wockhardt | Loading... | Small-cap | 0 | 0.66 | -38.82 | -17.32 |
